Shanghai – October 21, 2026 -- WuXi Biologics (2269.HK) won the Jade Award, the highest distinction at The Asset Corporate Sustainability Leadership Awards 2026, and was the only pharmaceutical company among this year's Jade recipients. The contract research, development and manufacturing organization (CRDMO) also took the Best in Transition (Hong Kong) award.